Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gloria Bachmann
Patient Satisfaction in Postmenopausal Women Treated With a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
Journal of Women's Health
Medicine
Drospirenone/Ethinyl Estradiol 3 Mg/20 &Micro;g (24/4 Day Regimen): Hormonal Contraceptive Choices &Ndash; Use of a Fourth-Generation Progestin
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Related publications
Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women
Journal of Internal Medicine
Internal Medicine
Improved Compliance and Patient Satisfaction With Estradiol Vaginal Tablets in Postmenopausal Women Previously Treated With Another Local Estrogen Therapy
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
Correction To: Effectiveness of Monthly Intravenous Ibandronate on the Low Responders to Oral Bisphosphonate: The MOVEMENT Study
Journal of Bone and Mineral Metabolism
Sports Medicine
Endocrinology
Orthopedics
Medicine
Metabolism
Diabetes
Profile of Changes in Bone Turnover Markers During Once-Weekly Teriparatide Administration for 24 Weeks in Postmenopausal Women With Osteoporosis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Bone Metabolism Genes Variation and Response to Bisphosphonate Treatment in Women With Postmenopausal Osteoporosis
PLoS ONE
Multidisciplinary
Long-Term Oral Bisphosphonate Use in Relation to Fracture Risk in Postmenopausal Women With Breast Cancer
Menopause
Gynecology
Obstetrics
Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide
Bone Research
Endocrinology
Physiology
Histology
Metabolism
Diabetes
Once-Weekly Albiglutide in the Management of Type 2 Diabetes: Patient Considerations
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics